Redefining drug therapy: innovative approaches using catalytic compartments
Yasemin Leyla Mustafa1, Arianna Balestri1, Xinan Huang1
1Department of Chemistry, University of Basel, Basel, Switzerland.
Expert Opinion on Drug Delivery
|September 11, 2024
Summary
Polymer-based catalytic compartments enable localized, on-demand drug production, overcoming short half-lives. These advanced systems mimic cellular functions for improved therapeutic delivery and precision medicine applications.
Area of Science:
- Polymer chemistry
- Biomedical engineering
- Catalysis
Background:
- Short drug half-lives necessitate frequent dosing.
- Catalytic compartments (nano- and microreactors) enable in situ therapeutic agent production.
- Polymer-based compartments offer stability, controlled permeability, and stimulus responsiveness.
Purpose of the Study:
- To review advancements in synthetic catalytic compartments.
- To focus on design, building blocks, active molecules, and bio-applications.
- To highlight their potential in precision medicine.
Main Methods:
- Exploration of polymer-based compartment design strategies.
- Analysis of building blocks and active molecules for catalytic compartments.
- Review of key biological applications of these systems.
Main Results:
- Polymer compartments mimic cellular functions for controlled catalysis.
- These systems facilitate localized compound generation and selective release.
- Advancements focus on enhancing reaction efficiency and site-specific delivery.
Conclusions:
- Catalytic compartments offer transformative potential for precision medicine.
- On-site production of therapeutics can improve treatment outcomes.
- Challenges in manufacturing, biodegradability, and regulation need addressing for clinical translation.
Related Concept Videos
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
83
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
83
01:16Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
01:30Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K
01:28Structure-Activity Relationships and Drug Design
677
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
677
01:26Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K